Sacubitril/valsartan compared to ramipril in high risk post myocardial infarction patients stratified according use of mineralocorticoid receptor antagonists: insight from …

M Schou, B Claggett, A Fernandez… - European Heart …, 2022 - academic.oup.com
Abstract Background Mineralocorticoid receptor antagonists (MRAs) reduce the risk of
cardiovascular death or heart failure admission in patients with myocardial infarction (MI) …
相关文章

Sacubitril/valsartan compared to ramipril in high risk post myocardial infarction patients stratified according use of mineralocorticoid receptor antagonists: insight from …

M Schou, B Claggett, A Fernandez… - European Heart …, 2022 - academic.oup.com
Abstract Background Mineralocorticoid receptor antagonists (MRAs) reduce the risk of
cardiovascular death or heart failure admission in patients with myocardial infarction (MI) …